Immunomedics Inc. | Cash Flow
Fiscal year is July-June. All values USD Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
35,531.20
48,124.00
59,135.70
153,266.30
273,887.00
Depreciation, Depletion & Amortization
569.40
578.10
737.70
923.30
1,297.30
Other Funds
331.70
585.70
369.00
547.00
1,521.50
Funds from Operations
34,378.70
43,727.30
53,321.30
78,108.00
125,232.70
Changes in Working Capital
3,467.50
4,731.10
4,859.50
15,857.90
8,718.10
Net Operating Cash Flow
30,911.20
38,996.20
48,461.80
62,250.10
133,950.90
Capital Expenditures
378.00
924.40
2,226.30
1,837.20
9,974.70
Purchase/Sale of Investments
34,871.10
51,815.90
48,101.00
74,426.50
84,731.70
Net Investing Cash Flow
34,849.10
52,740.30
45,874.70
76,263.70
74,757.10
Issuance/Reduction of Debt, Net
-
96,342.80
-
-
181,685.90
Net Financing Cash Flow
31,277.10
98,717.00
2,364.00
168,803.50
627,902.50
Net Change in Cash
34,364.50
6,491.30
249.20
30,189.90
568,662.90
Free Cash Flow
31,289.20
39,920.60
50,688.10
64,087.30
143,925.60
Other Sources
400.00
-
-
-
-
Change in Capital Stock
31,608.80
2,959.90
2,733.00
169,350.50
447,738.10
Exchange Rate Effect
118.70
489.20
26.00
99.70
45.80
About Immunomedics
View Profile
